NSAID, proton pump combo.
Prevacid NapraPAC (lansoprazole delayed-release capsules and naproxen tablets kit) is now approved for reduction of NSAID-associated gastric ulcers in patients with a history of a documented gastric ulcer who require the use of an NSAID for the treatment of the signs and symptoms of rheumatoid arthritis, osteoarthritis and ankylosing spondylitis. The blister packs come in 15-mg lansoprazole/250-mg naproxen, 15-mg/375-mg, and 15-mg/500-mg doses. For more information, contact Tap Pharmaceutical Products Inc., call 800-622-2011, or on the web at www.prevacid.com/naprapac/pi.
|Printer friendly Cite/link Email Feedback|
|Publication:||OB GYN News|
|Date:||Jan 1, 2004|
|Previous Article:||Weather does aggravate joint symptoms: folklore confirmed.|
|Next Article:||Panel backs OTC switch for Plan B: emergency contraception.|